Keratin intermediate filaments in the colon: guardians of epithelial homeostasis
Sarah Baghestani; Diana M. Toivola; Catharina M. Alam; Lauri Polari; Mina Tayyab; Joel H. Nyström; Taina Heikkilä
Keratin intermediate filaments in the colon: guardians of epithelial homeostasis
Sarah Baghestani
Diana M. Toivola
Catharina M. Alam
Lauri Polari
Mina Tayyab
Joel H. Nyström
Taina Heikkilä
PERGAMON-ELSEVIER SCIENCE LTD
Julkaisun pysyvä osoite on:
https://urn.fi/URN:NBN:fi-fe2022021519202
https://urn.fi/URN:NBN:fi-fe2022021519202
Tiivistelmä
Keratin intermediate filament proteins are major cytoskeletal components of the mammalian simple layered columnar epithelium in the gastrointestinal tract. Human colon crypt epithelial cells express keratins 18, 19 and 20 as the major type I keratins, and keratin 8 as the type II keratin. Keratin expression patterns vary between species, and mouse colonocytes express keratin 7 as a second type II keratin. Colonic keratin patterns change during cell differentiation, such that K20 increases in the more differentiated crypt cells closer to the central lumen. Keratins provide a structural and mechanical scaffold to support cellular stability, integrity and stress protection in this rapidly regenerating tissue. They participate in central colonocyte processes including barrier function, ion transport, differentiation, proliferation and inflammatory signaling. The cell-specific keratin compositions in different epithelial tissues has allowed for the utilization of keratin-based diagnostic methods. Since the keratin expression pattern in tumors often resembles that in the primary tissue, it can be used to recognize metastases of colonic origin. This review focuses on recent findings on the biological functions of mammalian colon epithelial keratins obtained from pivotal in vivo models. We also discuss the diagnostic value of keratins in chronic colonic disease and known keratin alterations in colon pathologies. This review describes the biochemical properties of keratins and their molecular actions in colonic epithelial cells and highlights diagnostic data in colorectal cancer and inflammatory bowel disease patients, which may facilitate the recognition of disease subtypes and the establishment of personal therapies in the future.
Kokoelmat
- Rinnakkaistallenteet [19207]